Tebentafusp Clinical Trials (2026): 14 Studies for Metastatic Uveal Melanoma & Uveal Melanoma

Where to Participate: All Tebentafusp Trial Sites in the U.S. (48 sites across 24 states)

Every actively recruiting Tebentafusptrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

Tebentafusp clinical trials at a glance: phase × recruitment status

Recruiting Tebentafusp clinical trials (10)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

Tebentafusp clinical trials by indication

Tebentafusp pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

Terminated and withdrawn Tebentafusp trials (1)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

• NCT02535078withdrawnPhase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma

All Tebentafusp trials (14)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

Tebentafusp clinical trials: frequently asked questions

How many Tebentafusp clinical trials are there?

14 Tebentafusp clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 10 are actively recruiting participants.

Are Tebentafusp clinical trials recruiting in 2026?

Yes — 10 Tebentafusp trials are actively recruiting in 2026, with 48 U.S. sites across 24 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Tebentafusp being studied for?

Tebentafusp is being studied for Metastatic Uveal Melanoma, Uveal Melanoma, Clear Cell Sarcoma (CCS), HLA-A*0201 Positive Cells Present, Locally Advanced Unresectable Uveal Melanoma and 8 more. The trials are grouped by indication on this page.

What phase is Tebentafusp in?

Tebentafusp clinical trials span 2 Phase 3, 7 Phase 2, 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Tebentafusp clinical trials?

The lead sponsor across the most Tebentafusp trials is Immunocore Ltd, with 9 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Tebentafuspas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed July 17, 2026.